Rb þ /À mice develop a complex spectrum of neuroendocrine tumors on a mixed genetic (129Sv Â C57BL/6) background. To understand how the 129Sv and C57BL/6 contributions affect Rb þ /À tumorigenesis, we serially backcrossed Rb þ /À animals to the 129Sv or C57BL/6 strain, and analysed their pathological profiles. Strikingly, the length of survival and the penetrance, severity and multiplicity of neuroendocrine tumors switch dramatically between Rb þ /À animals from the two genetic backgrounds. In fact, the 129Sv background significantly enhances both the initiation and progression of tumorigenesis in the intermediate lobe of the pituitary (ILP) in Rb þ /À animals. This is due to the surprising fact that ILPs from wild-type 129Sv animals are inherently abnormal, and thus greatly predisposed to neoplasia. This is likely to explain the high incidence of ILP tumors, an otherwise rare tumor type in wild-type mice, in numerous knockout studies performed on the 129Sv strain, and raises the intriguing possibility that the classic Rb þ /À neuroendocrine tumors may fade away in another as of yet unidentified inbred strain. Finally, we have increased the utility of the Rb þ /À tumor model, since Rb þ /À animals on the C57BL/6 background develop high-penetrance tumors of the anterior lobe of the pituitary, a class of tumors estimated to occur in 20-25% of humans.
Introduction
Inactivation of the retinoblastoma tumor suppressor (pRB) pathway appears to be an obligatory step toward neoplastic progression, as mutations in the RB gene or in the genes encoding or controlling its upstream regulators (e.g., cyclin D1, p16INK4A) are found in almost all human tumors (Sherr and McCormick, 2002) . The retinoblastoma tumor suppressor (pRB) is the prototypic member of the class of tumor suppressors known as 'gatekeepers ' (Kinzler and Vogelstein, 1998) , which control tumor growth in a cell autonomous manner by minimally controlling proliferation. When reintroduced into tumor cells, pRB can stop the growth of tumor cells by acting as a brake on the cell cycle, which has been attributed mainly to its ability to repress the action of the E2F/DP family of transcription factors, which act as bifunctional transcriptional switches to stimulate cell cycle progression or apoptosis, depending on the presence of environmental signals (Classon and Harlow, 2002; Trimarchi and Lees, 2002; Yamasaki, 2003) . The ability to bind E2F/DP transcription factors correlates with the phosphorylation state of pRB, being high when pRB is hypophosphorylated in G1, and low when pRB is hyperphosphorylated in S and G2 phases, resulting from the sequential action of D-, E-and Atype cyclin-mediated Cdk activity. When pRB is tethered via E2F1-3 to an E2F target gene and also complexed to histone deacetylases (HDACs), active repression of chromatin results as neighboring nucleosomes are modified (Trimarchi and Lees, 2002) .
E2F targets include genes that encode products that regulate the initiation or execution of DNA replication (e.g., Orc1, Dhfr, Rnr, Tk, Pola) , cell cycle progression (e.g., cyclin A and E, E2F1-3, pRb, p107) and apoptosis (e.g., Myc, Arf, Apaf, p73), and this helps explain the ability of pRB overexpression to cause a G1 arrest of the cell cycle. More recently identified E2F targets include genes whose products function in DNA repair (e.g., Msh2, Mlh1, Rad51), cell cycle checkpoints (e.g., Chk1) and mitotic regulation (e.g., Cdc2, cyclin B, Cdc35a, Bub3, Smc2) (Ishida et al., 2001; Kalma et al., 2001; Ma et al., 2002; Weinmann et al., 2002; Wells et al., 2002; reviewed in Stevaux and Dyson, 2002; Cam and Dynlacht, 2003) .
Despite the existence of multiple pRB family members, and their apparent biochemical similarities in vitro or in overexpression systems, there is ample evidence that these family members do not function interchangeably in vivo, and that pRB is unique in its ability to suppress tumor development in humans and in mice. Rb-deficient mice die in mid-gestation with ectopic proliferation and widespread apoptosis in the CNS, PNS, lens and fetal liver (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) . Recently, death of the Rbdeficient embryos has been demonstrated to be due to placental insufficiency, leading secondarily to apoptosis in the embryo proper Wu et al., 2003) . Consistent with the central role of pRB as a tumor suppressor, all of the Rb þ /À mice develop neuroendocrine tumors, arising in the intermediate lobe of the pituitary (ILP) and in the medullary component of the thyroid (C-cells) (Jacks et al., 1992; Hu et al., 1994; Harrison et al., 1995) . In contrast, the p107-or p130-deficient mice are viable and tumor free on a mixed genetic background, and p130-deficient;p107-deficient mice die at birth with defective chondrocyte development (Cobrinik et al., 1996; Lee et al., 1996) . Inactivation of all or multiple pRB family members is needed to immortalize primary mouse embryonic fibroblasts (MEFs), making them insensitive to the status of p53 -data arguing that normally these proteins coordinately regulate cellular senescence (Dannenberg et al., 2000; Sage et al., 2000; Peeper et al., 2001) .
In many respects, the Rb þ /À mice develop tumors similar to the inherited retinoblastoma patients that carry germline mutations in one RB allele. Tumor susceptibility is highly penetrant, in mice reaching nearly 100%. Furthermore, tumorigenesis is rate-limited by the loss of the remaining wild-type allele, as demonstrated by the fact that chimeras constructed with Rb-deficient embryonic stem cells succumb to ILP tumors much earlier than the Rb þ /À animals (Maandag et al., 1994; Williams et al., 1994b) . The most obvious difference in tumors developing in RB þ /À humans and Rb þ /À mice is the tissue specificity that is displayed. Patients with germline RB mutations develop retinoblastomas in early childhood (o5 years of age) and osteosarcomas later in life, while Rb þ /À mice develop neuroendocrine tumors in the ILP and thyroid. Engineering mutant mice that develop retinoblastoma has been achieved only through the transgenic expression of SV40-T or the simultaneous inactivation of Rb and p107 in chimeric animals (Windle et al., 1990; Robanus-Maandag et al., 1998) .
The fully penetrant pituitary (ILP) tumorigenesis that occurs in the Rb þ /À animals has been an excellent model with which to test for genetic interaction with the Rb tumor suppressor pathway. Previously, we demonstrated that inactivation of E2f1 inhibits neuroendocrine tumorigenesis in Rb þ /À mice by reducing the penetrance and severity of tumors, thereby extending the lifespan of Rb þ /À animals (Yamasaki et al., 1998) . Curiously, inactivation of E2F4 also extends the lifespan of Rb þ /À animals by liberating more p107 and p130 to bind E2F family members normally bound by pRB (Lee et al., 2002) . Loss of Cip1 (p21) enhances ILP tumorigenesis and shortens the lifespan of Rb þ /À animals (Brugarolas et al., 1998) , as does loss of Kip1 (p27) (Park et al., 1999) . However, loss of Kip1 alone leads to ILP adenomas (less severe than the ILP adenocarcinomas arising in the Rb þ /À animals), while loss of only Cip1 does not lead to an ILP lesion (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996) . Additionally, loss of Ink4c (p18) leads to ILP hyperplasia, which is enhanced by loss of Kip1 or Cip1 (Franklin et al., 1998 (Franklin et al., , 2000 . Finally, loss of Trp53 (p53) or Arf (p19) enhances ILP tumorigenesis in Rb þ /À animals, albeit by distinct pathways (Williams et al., 1994a; Tsai et al., 2002) .
Previously, we have reported that Rb þ /À mice die earlier on a 129Sv inbred background, 3 months earlier than Rb þ /À mice on a mixed 129Sv Â C57BL/6 genetic background (8 vs 11 months) (Yamasaki et al., 1998) . Interestingly, loss of one allele of E2f1 abolished this 129Sv-specific reduction of lifespan of Rb þ /À animals, suggesting that E2f1 or an E2f1-regulated gene acts as a genetic modifier of Rb þ /À lifespan. After backcrossing mixed genetic background Rb þ /À;E2f1 þ /À animals once to the C57BL/6 strain, we noted a change in the severity of their tumor profile. To understand how each of these genetic backgrounds influences the Rb þ /À neuroendocrine tumor phenotype, we serially backcrossed 10 generations from a single Rb þ /À founder towards the 129Sv or C57BL/6 strain. We now report that the Rb þ /À tumor profile switches dramatically with genetic background, and that this tumor switch is mainly due to previously unknown ILP abnormalities inherent in the 129Sv strain.
Results
Serial backcrossing of Rb þ /À animals on the 129Sv or C57BL/6 background To determine how genetic background influenced the tumor spectrum and survival of Rb þ /À animals, we backcrossed an Rb þ /À founder (E2800) from a mixed genetic background G0 cohort to either the 129S4/SvJae (hereafter referred to as 129Sv) or the C57BL/6 strain. This Rb þ /À animal represents one additional backcross to the C57BL/6 strain, from the colony used in our previous work as 'mixed' genetic background (Yamasaki et al., 1998) . We serially backcrossed this progeny nine more generations to either the 129Sv or C57BL/6 strains, to ensure that the uniformity of the genetic background was at least 99.6%. For the sake of simplicity, we have arbitrarily grouped these Rb þ /À animals into six cohorts, including the original G0 cohort (n ¼ 45), according to the level of backcrossing achieved. For the 129Sv Rb þ /À cohorts, we have grouped generations G1-G4 (n ¼ 38), G5-G8 (n ¼ 28) and G9-G10 (n ¼ 30). Similarly, we have grouped these Rb þ /À animals in cohorts for the C57BL/6 generations G2-G4 (n ¼ 16) and G5-G8 (n ¼ 42). Approximately 96.9-99.6% of the G5-G8 genome is derived from the strain to which they have been backcrossed, while for G9-G10 animals, the contribution is approximately 99.8-99.9%.
Survival of Rb þ /À animals on the 129Sv or C57BL/6 background Rb þ /À animals were monitored for precipitous changes in health, at which point they were killed and tumor burden was assessed. Co-housed wild-type littermates from each generation were killed at similar time points to act as healthy controls, and in no instance did we detect neuroendocrine tumors in these wild-type littermates. Six cohorts were followed, corresponding to Rb þ /À animals from the G0 group, the 129Sv G1-G4, 129Sv G5-G8, 129Sv G9-G10 backcrosses, and the C57BL/6 G2-G4 and C57BL/6 G5-G8 backcrosses. Survival curves for these six Rb þ /À cohorts are shown in Figure 1 , and the mean ages of survival and the ranges of survival for all six Rb þ /À cohorts are listed in Table 1 . The mean ages of survival for the individual generations rather than the grouped cohorts are listed in Supplementary Table 1. The survival of the C57BL/6 G5-G8 Rb þ /À cohort is enhanced significantly compared to that of the G0 Rb þ /À cohort, as visualized by a rightward shift of the C57BL/6 G5-G8 survival curve (Figure 1) . The difference in the mean age of survival between the C57BL/6 G5-G8 (370.9710.2 days) and G0 (321710.6 days)
Rb þ /À cohorts is statistically significant (Table 1 , oneway ANOVA analysis, ro0.001). Extension of Rb þ /À lifespan by increasing the contribution of the C57BL/6 genetic background has never been reported previously.
Survival of the three 129Sv Rb þ /À cohorts is substantially shorter than that of the G0 Rb þ /À cohort, as visualized by leftward shifts of the 129Sv Rb þ /À survival curves (Figure 1) . The difference in the mean age of survival between the 129Sv G9-G10 (251.276.4 days) and G0 (321.8710.6 days) cohorts is highly statistically significant (Table 1 , one-way ANO-VA analysis, ro0.001) and consistent with that we reported previously for inbred 129Sv Rb þ /À animals (254726 days) compared to that for mixed genetic background Rb þ /À animals (340758 days) (Student's t-test, ro0.001) (Yamasaki et al., 1998) .
Thus, by backcrossing the G0 founder (E2800) to either the 129Sv strain or the C57BL/6 strain, we have shortened (for 129Sv G9-G10, 251.276.4 days) or lengthened (for C57BL/6 G5-G8, 370.9710.2 days) the mean age of Rb þ /À survival dramatically ( Figure 1 and Table 1 , one-way ANOVA analysis, ro0.001). Put simply, C57BL/6 Rb þ /À animals live 4 additional months relative to their 129Sv Rb þ /À counterparts, gaining 50% of the 129Sv Rb þ /À expected lifespan. In fact, the oldest surviving C57BL/6 Rb þ /À animal died at 530 days (G7), which is 200 days or 6.7 months after the oldest surviving 129Sv G10 Rb þ /À animal died. These data demonstrate that genetic modifiers exist, which change the survival of Rb þ /À animals in a strain-specific manner. This could be due to a difference in the 129Sv strain, which renders Rb þ /À animals more vulnerable to tumor development or a difference in the C57BL/6 strain, which protects Rb þ /À animals against tumorigenesis.
Strain-specific changes in the Rb þ /À tumor penetrance and severity Previously, we observed that Rb þ /À animals on a 129Sv or mixed genetic background die with adenocarcinomas of the ILP (95%), and a subset of these (53%) develop thyroid C-cell adenomas or hyperplasia (Yamasaki et al., 1998) . After a single C57BL/6 backcross, we found that our G0 Rb þ /À cohort developed a spectrum of neuroendocrine tumors, including tumors of the ILP, thyroid and anterior lobe of the pituitary (ALP). The G0 Rb þ /À cohort developed these three Figure 1 G0 Rb þ /À survival changes with increasing 129Sv or C57BL/6 contribution. Rb þ /À mice were serially backcrossed from a single G0 founder 7 or 10 generations to the C57BL/6 or 129Sv genetic background, respectively. Different generations were grouped into the following Rb þ /À cohorts: 129Sv G9-G10, 129Sv G5-G8, 129Sv G1-G4, G0, C57BL/6 G2-G4 and C57BL/6 G5-G8. Animals were killed just before their natural endpoint, and survival curves were constructed, in which percent survival is plotted against the age of death (days) for each Rb þ /À cohort. The 129Sv background shortens Rb þ /À lifespan, while the C57BL/6 background extends Rb þ /À lifespan relative to that of the G0 cohort Individual generations were arbitrarily grouped into these cohorts based on the level of backcrossing achieved. For mean survival of each generation, see Supplementary Table 1. b For historical reasons, the G0 cohort is also the C57BL/6 G1 generation, comprised of Rb+/À animals that arose from interbreeding Rb+/À;E2f1+/À animals neuroendocrine tumors, arising in the ILP with 74% penetrance (n ¼ 42), in the ALP with 51% penetrance (n ¼ 41) and in the thyroid with 88% penetrance (n ¼ 43) (Figure 2 ). Half of all ILP and ALP tumors in the G0 Rb þ /À cohort were given a severity score of '3' upon gross dissection, indicating that the lesion was advanced enough to contribute to the cause of death (Table 2) . Backcrossing the Rb þ /À animals to either the 129Sv or C57BL/6 strains caused the penetrance and severity of these tumors to segregate in different ways as reported now below.
Animals within the 129Sv G9-G10, G5-G8 and G1-G4 Rb þ /À cohorts developed ILP tumors with 100% penetrance (n ¼ 29, 28 and 38, respectively), a significant increase from the 74% penetrance observed in the G0 cohort (n ¼ 42, w 2 test, r ¼ 0.003 for the 129Sv G9-G10 and G0 comparison) ( Figure 2 , black bars). In contrast, animals within the C57BL/6 G5-G8 Rb þ /À cohort developed ILP tumors with only 58% penetrance (n ¼ 36), a significant reduction from the 100% penetrance seen in the 129Sv G9-G10 Rb þ /À cohorts (w 2 test, ro0.0002). This is especially intriguing, because the ILP tumors are considered in general to be the invariant Rb þ /À tumor phenotype. Furthermore, almost all of ILP tumors arising in the 129Sv G9-G10 (25/ 29), 129Sv G5-G8 (26/28) and 129Sv G1-G4 (36/38) Rb þ /À cohorts were given a severity score of '3' upon gross dissection, advanced enough to be the suspected cause of death, while only a minority (5/21) of ILP tumors arising in the C57BL/6 G5-G8 Rb þ /À cohort were scored so ( Table 2 ). The increase in severity of the ILP tumor with the 129Sv background is highly significant (for each pairwise comparison with C57BL/ 6 G5-G8, w 2 test, ro0.0001). Taken together, these data strongly suggest that the 129Sv genetic background enhances the penetrance and the severity of the ILP tumors.
In contrast to the situation with ILP tumorigenesis, 65% of animals in the C57BL/6 G5-G8 Rb þ /À cohort (n ¼ 40) and 79% of the C57BL/6 G2-G4 Rb þ /À cohort (n ¼ 14) developed ALP tumors, while only a very small fraction of the 129Sv G9-G10 (7%, n ¼ 27) and 129Sv G5-G8 (11%, n ¼ 28) Rb þ /À cohorts and none of the 129Sv G1-G4 Rb þ /À cohort (n ¼ 30) did so (w 2 test, ro0.0001 for all 129Sv vs all C57BL/6 cohorts) (Figure 2, gray bars) . The ALP tumors are histologically Figure 2 Rb þ /À neuroendocrine tumor penetrance switches with genetic background. Upon killing just before their natural end point, Rb þ /À mice were evaluated for the presence or absence of tumors in the ILP (black bars), ALP (gray bars) or thyroid (white bars). After gross dissection, the identity of the tumor lesion was assigned histopathologically. All of the pituitary tumors and almost all the thyroid tumors were also confirmed with immunohistochemical staining using antibodies to a-MSH for the ILP melanotropic tumors, calcitonin for thyroid C-cell tumors and a-GSU for ALP tumors. With increasing 129Sv contribution, Rb þ /À cohorts develop the ILP tumor with 100% penetrance. With increasing C57BL/6 contribution, Rb þ /À cohorts develop the thyroid tumor with 90% penetrance and the ALP tumor with at least 65% penetrance. The statistical significance of these changes is stated in the Results section For ILP and ALP tumor severity, only those animals that developed an ILP or ALP tumor were scored (the numerators in penetrance from Figure  2 ). A severity score or grade of 1-3 was given based on size. A score of 1 ¼ o1.5 mm, a score of 2 ¼ 2-4 mm and a score of 3 ¼ 45 mm
Rb þ /À neuroendocrine tumor switch SW Leung et al distinct from the ILP tumors, and yet we also confirmed with immunohistochemical staining that they do not secrete a-MSH. More than half of these ALP tumors stain positively (at least a portion of the tumor section) for the alpha-glycoprotein subunit (a-GSU) (data not shown), which identifies a subset of cell types in the ALP, secreting TSH, FSH and LH. The sharp increase in ALP tumors we recovered in the C57BL/6 Rb þ /À cohorts demonstrated that the C57BL/6 genetic background strongly enhances the development of the ALP tumor. Again, in contrast to the case with ILP tumorigenesis, the severity of the ALP tumor lesions is high on either genetic background ( Table 2 , 13/26 vs 2/2 grade '3' ALP tumors in the 129Sv G9-G10 and C57BL/ 6 G5-G8 cohorts, respectively). Minimally, ALP tumors are not the cause for the significantly shortened survival of 129Sv Rb þ /À animals. Nearly all (90%) animals in the C57BL/6 G5-G8 Rb þ /À cohorts (n ¼ 41) developed thyroid tumors, while only 47% of animals in the 129Sv G9-G10 (n ¼ 30) Rb þ /À cohort did so (w 2 test, ro0.0001) (Figure 2 , white bars). Furthermore, only one of the 14 129Sv G9-G10 Rb þ /À animals with thyroid tumors (7%) developed a large (45 mm) thyroid tumor (range of tumor diameter observed 0.1-5 mm, average ¼ 1.5 mm), while 68% of the C57BL/6 G5-G8 Rb þ /À animals with thyroid tumors (n ¼ 37) developed severe thyroid lesions (range of tumor diameter observed 0.5-15.0 mm, average ¼ 6.5 mm), enough to be the suspected cause of death (Figure 3 ). This difference in thyroid tumor size is statistically significant (twosample t-test with unequal variance, ro0.0001). Additionally, a greater percentage of Rb þ /À animals developed bilateral vs unilateral thyroid tumors on the C57BL/6 background (e.g., 43% of C57BL/6 G5-G8 (n ¼ 37) vs 7% of 129Sv G5-G8 (n ¼ 14)) (w 2 test, ro0.02). Clearly, the C57BL/6 genetic background greatly enhances the penetrance and severity of thyroid tumorigenesis (Figure 3) , and thus thyroid tumorigenesis cannot be the cause of the significantly shortened survival of 129Sv Rb þ /À animals.
Strain-specific changes in Rb þ /À tumor multiplicity
At the time of death, we observed that nearly all (43/44) G0 Rb þ /À animals, all 129Sv Rb þ /À animals (95/95) and all C57Bl/6 Rb þ /À animals (58/58) developed at least one of these neuroendocrine tumors; however, many individual Rb þ /À animals developed multiple tumor types. Importantly, the 129Sv or C57BL/6 genetic background dictates the multiplicity of tumor types found in individual Rb þ /À animals ( Figure 4 , includes only animals for which all three tissues were recovered). Thus, 100% of the 129Sv G9-G10 Rb þ /À animals (n ¼ 26) developed ILP tumors (the presumed cause of death), 42% of which also developed thyroid tumors. Only one out of 26 animals of the 129Sv G9-G10 Rb þ /À cohort developed an ALP tumor in addition to the ILP tumor (4%), and none of the animals in this cohort developed all three neuroendocrine tumor types. In striking contrast, 82% of the C57BL/6 G5-G8 Rb þ /À animals (n ¼ 34) developed thyroid tumors in conjunction with ILP tumors or ALP tumors, and 24% developed all three tumor types, which is highly significant (comparison for development of all three tumor types, w 2 test, ro0.005). The increase in Rb þ /À multiple tumor burden with C57BL/6 genetic background is highly significant (129Sv G9-G10 vs C57BL/6 G5-G8 for one vs multiple tumor types, w 2 test, ro0.001). Perhaps the most interesting aspect of the tumor burden (as judged by the multiplicity of tumors found per animal) is that although the C57BL/6 G5-G8 Rb þ /À cohort has the greater tumor burden, it paradoxically lives the longest. This is most likely due to the fact that the large ILP tumors, which are more prevalent in the 129Sv background than the C57BL/6 Figure 3 Rb þ /À thyroid tumor severity increases with C57BL/6 contribution. The severity of the thyroid C-cell tumor was evaluated by measuring the diameter of the lesion (under a dissecting microscope). Thyroid tumor diameter is plotted in a scattergram for each cohort. Dark, bolded circles represent two or more identically sized thyroid tumors. Circles shifted to the right indicate the smaller tumor of a bilateral thyroid tumor pair. Small gray bars indicate the mean thyroid tumor size for each cohort, using only the largest tumor found per animal. Mean thyroid tumor sizes are listed as follows: 1.5 mm for the 129Sv G9-G10 cohort (n ¼ 14 tumors); 1.1 mm for the 129Sv G5-G8 cohort (n ¼ 11 tumors); 2.7 mm for the 129Sv G1-G4 cohort (n ¼ 17 tumors); 4.0 mm for the G0 cohort (n ¼ 38 tumors); 5.7 mm for the C57BL/6 G2-G4 cohort (n ¼ 13 tumors); 6.5 mm for the C57BL/6 G5-G8 cohort (n ¼ 37 tumors). Increasing C57BL/6 contribution increases the severity of the thyroid C-cell tumors in Rb þ /À cohorts (two-sample t-test with unequal variance, ro0.0001). The incidence of bilateral thyroid tumors also increases substantially on the C57BL/6 genetic background (7% in the 129Sv G9-G10 cohort, 42% in the G0 cohort and 43% in the C57BL/6 G5-G8 cohort, w 2 test, ro0.02) background (Table 2) , are more deadly or less sustainable due to their intercranial location than the large thyroid tumors, which are more prevalent in the longerlived C57BL/6 background ( Figure 3) . Additionally, 35% of the C57BL/6 G5-G8 Rb þ /À cohort (n ¼ 34) developed thyroid tumors in the absence of an ILP tumor, which clearly demonstrates that the development of the thyroid tumor is not dependent on the presence of the ILP tumor or any hormonal imbalance imposed by the ILP tumor. These data are consistent with the notion that strain-specific genetic modifiers exist, which change Rb þ /À survival and penetrance, severity and multiplicity of neuroendocrine tumors in Rb þ /À animals. Hypothetically, this could be due to a difference in the 129Sv strain, which renders Rb þ /À animals more vulnerable to ILP tumor development, or a difference in the C57BL/6 strain, which offers protection to Rb þ /À animals from the life-threatening effects of tumorigenesis.
Analysis of early ILP and thyroid lesions
To understand how the 129Sv genetic background changed the penetrance and severity of the neuroendocrine tumor profiles in the Rb þ /À cohorts so dramatically, we examined 129Sv G10, G0, and C57BL/6 G10 Rb þ /À animals at 6 months of age ( Figure 5 ). Lesions in the ILP or thyroid were scored as either early atypical proliferates (EAPs) or tumors. Remarkably, 94% of the 129Sv G10 Rb þ /À cohort (n ¼ 16) developed ILP tumors by 6 months of age, while only 29% of the G0 Rb þ /À cohort (n ¼ 17) and 7% of the C57BL/6 G10 cohort (n ¼ 15) did so (black bars in Figure 5a , w 2 test, ro0.00001). Similarly, 100% of the 129Sv G10 Rb þ /À cohort developed ILP lesions (tumors or EAPs) by 6 months of age, while 59% of the G0 Rb þ /À cohort and 13% of the C57BL/6 G10 cohort did so (black and gray bars in Figure 5a , w 2 test, ro0.00001). This acceleration of ILP tumorigenesis is also evident at 3 months of age, where 47% of the 129Sv G10 Rb þ /À cohort (n ¼ 15) developed ILP lesions (tumors or EAPs), while only 6% of the G0 Rb þ /À cohort (n ¼ 18) and none of a C57BL/ 6 G10-G11 Rb þ /À cohort (n ¼ 13) did so ( Figure 5b , w 2 test, r ¼ 0.0012). Thus, the initiation and progression of ILP tumorigenesis is vastly accelerated on the 129Sv genetic background.
Surprisingly, approximately similar fractions of animals from the 129Sv G10 (31%, n ¼ 16), G0 (33%, n ¼ 18) and C57BL/6 G10 (20%, n ¼ 15) Rb þ /À cohorts developed thyroid lesions (tumors or EAPs) by 6 months of age, suggesting that the initiation of thyroid lesions is almost equivalent on the 129Sv, G0 and C57BL/6 genetic backgrounds (black and gray bars in Figure 5c ). At 6 months, we noted that a slightly greater percentage of the G0 Rb þ /À cohort (22%) developed thyroid tumors relative to that of the 129Sv G10 Rb þ /À cohort (13%); however, this difference was not enhanced with further backcrossing (C57BL/6 G10 Rb þ /À cohort developed only 20% of thyroid lesions) and is statistically insignificant. Since the 129Sv G10 Rb þ /À animals have a similar ability to initiate thyroid lesions, we conclude that small thyroid tumors and fewer bilateral thyroid tumors are seen in the 129Sv survival cohorts due to the 3-and 4-month shorter survival on the 129Sv background relative to that of G0 and C57BL/6 G5-G8 Rb þ /À cohorts, respectively.
Taken together, the analysis of the 3-and 6-month time points resolves the C57BL/6 paradox of longer Rb þ /À lifespan with greater tumor burden. The 129Sv Rb þ /À animals die sooner with a lower overall tumor burden, primarily because their fully penetrant, more aggressive lesion is an intercranial ILP tumor. Conversely, the C57BL/6 G5-G8 Rb þ /À animals die later with a greater overall tumor burden, because their small ILP tumors initiate less frequently, later and progress more slowly. Thus, the increased penetrance and severity in ILP tumorigenesis is the key to the dramatically different survival and tumor associations of the 129Sv Rb þ /À cohorts.
The wild-type 129Sv ILP is abnormal
The high penetrance (94%) of the ILP tumors observed in the 6-month 129Sv G10 Rb þ /À cohort suggested that the 129Sv genetic background strongly predisposes The height of each cone represents the penetrance with which it appeared in each of the Rb þ /À cohorts. Increasing C57BL/6 contribution greatly increased the multiplicity of neuroendocrine tumors found per Rb þ /À animal. In contrast, increasing the 129Sv contribution greatly reduced the penetrance of multiple tumors found per Rb þ /À animal these animals to develop ILP lesions. We reasoned that the 129Sv strain might be predisposed to developing ILP lesions, although there have been no previous reports of this possibility. Upon examining the ILPs from aged (48 months) wild-type 129Sv animals, we observed obvious histologic abnormalities that we did not observe in the ILPs from aged (46 months) wild-type C57BL/6 animals ( Figure 6a-f) . The aged wild-type 129Sv ILP contains generalized melanotrope enlargement with a high ratio of cytoplasmic to nuclear volume (90% penetrant, n ¼ 29, see Figure 6c and d) relative to those in the aged wild-type C57BL/6 ILP (0%, n ¼ 20). Furthermore, the aged wild-type 129Sv ILP is abnormally enlarged (55% penetrant, n ¼ 29, see Figure 6a and b), appearing 2-3 times the size of the wild-type C57BL/6 ILP (0%, n ¼ 20). Additionally, we detected uneven or patchy immunohistochemical staining for a-MSH in the wild-type 129Sv ILPs (60% penetrant, n ¼ 15, see Figure 6e and f), which was not observed in the wild-type C57BL/6 ILPs (n ¼ 10). We also examined ILPs from 3-to 4-month wild-type 129Sv animals (78% penetrant, n ¼ 18), which contained a predominance of enlarged melanotropes without overall ILP enlargement, consistent with the generalized melanotrope enlargement found in the aged 129Sv animals. Such melanotrope enlargement was not observed in ILPs from 3-month wild-type C57BL/6 animals (0%, n ¼ 18). This strongly suggests that 129Sv animals are predisposed to ILP tumorigenesis prior to the inactivation of even one Rb allele.
It is known that dopaminergic innervation during development normally inhibits the proliferation of the melanotropes that comprise the ILP (Gary and Chronwall, 1992), and insufficient dopaminergic innervation of the ILP is a non-tumor cell autonomous mechanism by which loss of one allele of Rb facilitates ILP tumorigenesis (Nikitin and Lee, 1996) . To investigate whether such an innervation defect exists in the wild-type 129Sv animals relative to that in the wild-type C57BL/6 animals resulting in overgrowth of the ILP, we immunohistochemically stained ILP tissue for tyrosine hydroxylase, which detects dopaminergic innervation (Figure 6g and h) . We detected substantial dopaminergic innervation of the ILPs from 3-month wild-type 129Sv as well as C57BL/6 animals. Slight differences in the punctate expression pattern of tyrosine hydroxylase appear only to be due to the melanotrope enlargement apparent in the wild-type 129Sv ILP, which disappear when normalized to melanotrope cell number.
The histological abnormalities in the aged wild-type 129Sv strongly suggested that the genetic modifiers responsible for the shortened survival, 100% penetrance and greater severity of ILP tumors in the 129Sv Rb þ /À animals are also responsible for the histologic abnormalities in the wild-type 129Sv ILP. To begin characterizing the 129Sv-specific genetic modifiers, we have generated an F1 cross between wild-type 129Sv and C57BL/6 animals, and analysed ILPs at 3 months for generalized melanotrope enlargement. This has demonstrated that the 129Sv-specific modifier genes do not act dominantly (0% generalized melanotrope enlargement, n ¼ 22).
As an initial attempt to identify candidate genetic modifiers, we monitored the expression pattern of 94 cell Figure 5 Rb þ /À ILP lesions develop faster with increasing 129Sv contribution. Rb þ /À animals at 3 and 6 months of age from the 129Sv G10, G0 and C57BL/6 G10 or G11 cohorts were evaluated for the development of the ILP and thyroid lesions upon gross dissection and histopathologically. Lesions were scored as tumors (denoted 'T' and as black bars) or EAPs (denoted 'E' and as gray bars), and only the most severe lesion per tissue is scored per animal. (a) Penetrance of ILP lesions at 6 months of age for each cohort. (b) Penetrance of ILP lesions at 3 months of age for each cohort. (c) Penetrance of thyroid lesions at 6 months of age for each cohort. With increasing 129Sv contribution, Rb þ /À animals develop ILP lesions (EAPs and tumors) much more rapidly than those on the G0 mixed or C57BL/6 background: difference at 6 months (a), w 2 test, ro0.00001 and difference at 3 months (b) w 2 test, r ¼ 0.0015 cycle-related genes (including cyclins, CKIs, E2F and Rb family members) in microdissected tissue (ILPs and posterior lobes) from 5-week-old wild-type 129Sv and C57BL/6 animals using a small microarray, but did not detect any obvious differences (data not shown). This analysis does not preclude the possibility that strainspecific differences in the coding sequences of these cell cycle targets are responsible for the ILP predisposition of the 129Sv strain. Since our previous work had indicated that E2f1 acts as a strain-specific modifier of the Rb þ /À tumor phenotype, we sequenced E2f1 cDNAs that we generated from the 129Sv and C57BL/6 strains. This revealed only minor cDNA differences in each of the E2f1 sequences available from the Swiss Webster strain (Li et al., 1994 ; Genbank accession #L21973), none of which would result in truncations or amino-acid changes (see Supplementary Figure 1) . Similarly, we have sequenced partial Rb cDNAs (encoding amino acids 280-921) that we generated from the 129Sv and C57BL/6 strains, and have detected no differences from the corrected Rb cDNA sequence available from the BALB/c strain (Bernards et al., 1989; Zacksenhaus et al., 1993 ; Genbank accession #M26391) or the C57BL/6 Rb Figure 6 The wild-type 129Sv pituitary is abnormal. Aged wild-type C57BL/6 animals (46 months) have a normal ILP, while aged wild-type 129Sv animals (48 months) display three histological abnormalities. Panels a, c and e are from a 12-month wild-type C57BL/6 female, while panels b, d and f are from an 8-month wild-type 129Sv female. The lobes of the pituitary are indicated (I ¼ ILP, A ¼ ALP, P ¼ posterior lobe of the pituitary). Panels a and b are hematoxylin and eosin (H&E)-stained pituitary sections at 10 Â , showing the overall ILP enlargement seen in 55% of aged wild-type 129Sv animals. Panels c and d are the boxed images (indicated in panels a and b) at 60 Â , showing the generalized melanotrope enlargement seen in 90% of aged wild-type 129Sv animals. Panels e and f are serial sections of the pituitary at 10 Â stained immunohistochemically for a-MSH, and show the uneven patchy a-MSH staining observed in 60% of aged wild-type 129Sv animals. Panels g and h show 60 Â images of the ILP from 3-month wild-type C57BL/6 and 129Sv animals, respectively, that have been stained immunohistochemically for tyrosine hydroxylase to detect dopaminergic innervation. The level of dopaminergic innervation is approximately equivalent between the C57BL/6 and 129Sv ILP, when staining is normalized to the number of nuclei visible in each section Rb þ /À neuroendocrine tumor switch SW Leung et al sequence from the NCBI mouse genome database (Genbank accession #NT_039606). Thus, no obvious differences in the sequences of E2f1 or Rb have been identified, which can explain the clear histological abnormalities that we have discovered in the wild-type 129Sv ILPs.
Discussion
One of the most intriguing, yet poorly understood, aspects of tumor suppression is the high tissue specificity of tumor susceptibility associated with the inherited mutations of tumor suppressor genes (Knudson, 1997) . It is not known how germline mutations in RB result in retinoblastoma and osteosarcoma at high penetrance, but not an array of other tumor types in humans. Even when sporadic mutations in human cancer are considered, there is a striking incidence (95-99%) of RB mutations in small cell lung carcinoma (SCLC), and a conspicuous absence of RB mutations in non-small cell lung carcinoma (NSCLC), in which alterations of the INK4A/ARF locus predominate (Harbour et al., 1988; Hayashi et al., 1994; de Vos et al., 1995; Okamoto et al., 1995; Kratzke et al., 1996) .
In this study, we have systematically dissected the complex neuroendocrine tumor phenotype of Rb þ /À animals on a mixed 129Sv Â C57BL/6 genetic background to understand what neoplastic contribution is made by each strain's genetic background. These strainspecific effects are strong, dictating when, where and how the Rb þ /À mutation leads to tumorigenesis. Clearly, the Rb þ /À tumor phenotype is dynamic, shifting dramatically in the length of survival and tumor penetrance, severity and multiplicity between the 129Sv and C57BL/6 genetic backgrounds. We have demonstrated that the key to this dynamic shift in the overall Rb þ /À tumor profile is the increased ILP tumor penetrance and severity that occurs in the 129Sv Rb þ /À animals. Finally, we have discovered that this increase in ILP tumor penetrance and severity in the 129Sv Rb þ /À animals can be traced to histological abnormalities (i.e., generalized melanotrope enlargement, ILP enlargement and uneven a-MSH staining) arising in the wild-type 129Sv animals.
The high penetrance of the histological abnormalities in wild-type 129Sv ILPs strongly suggests that there are 129Sv-specific genetic modifiers that greatly enhance the time course (initiation and progression) of ILP tumorigenesis in the 129Sv Rb þ /À animals. In theory, 129Sv-specific modifiers, for instance, that alter the timing of melanotrope commitment or that decrease DNA repair or the expression of Rb could enhance ILP tumorigenesis. However, we have a clue to help identify these modifiers. By 6 months of age, loss of E2f1 is as effective as serially backcrossing Rb þ /À animals to the C57BL/6 background for reducing ILP tumor and EAP development (S Leung and L Yamasaki, unpublished observations). Additionally, loss of one allele of E2f1 extends lifespan only on the 129Sv background (Yamasaki et al., 1998 ), yet no E2f1 coding differences exist between the 129Sv and C57BL/6 strains. Thus, it is likely that at least one of these 129Sv-specific modifiers is an E2f1 target gene. Experiments to map the approximate chromosomal location of the 129Sv genetic modifiers are underway.
An important implication of our observation that the wild-type 129Sv ILP is inherently abnormal, is that the wild-type 129Sv ILP is 'primed' or tumor-prone and requires less subsequent mutation to produce ILP tumors. This is likely to explain the high incidence of ILP tumors, an otherwise rare tumor type in wild-type mice of most laboratory strains, that has been reported with the inactivation not only of Rb (ILP adenocarcinomas), but also inactivation of Kip1 (ILP adenomas) or Ink4c (ILP hyperplasia) in knockout studies performed on the 129Sv Â C57BL/6 mixed genetic background. Furthermore, cooperation occurs between Rb loss and the inactivation of Cip1, Kip1, Arf or Trp53 as judged by shortened survival and increased ILP tumor severity (Williams et al., 1994a; Brugarolas et al., 1998; Park et al., 1999; Tsai et al., 2002) , as does cooperation between Ink4c and Kip1 or Cip1 for increased ILP tumor severity and shortened survival (Franklin et al., 1998 (Franklin et al., , 2000 . In contrast, loss of E2f1 or E2f4 lengthened survival and decreased the penetrance of the ILP tumors (Yamasaki et al., 1998; Lee et al., 2002) . More recently, loss of E2f3 has been shown to decrease the severity of the ILP tumors in Rb þ /À mice (Ziebold et al., 2003) . These results suggest that 129Sv-specific differences in any of these genes could act as genetic modifiers of the ILP tumor phenotype; however, in such studies, an inadvertent change in the C57BL/6 contribution of the mutant strains or segregation of the 129Sv modifier could be partly responsible for a change in pituitary tumorigenesis. Extending this line of reasoning, it is possible that the transfer of the engineered Rb mutant allele onto other genetic backgrounds will shift the Rb þ /À tumor phenotype to other target tissues, possibly non-neuroendocrine.
There have been several other reports of strainspecific effects in knockout studies focused on pRB or E2F family members, all performed on the mixed 129Sv Â C57BL/6 background. Loss of p130 results in embryonic lethality and loss of p107 results in myeloid hyperplasia and growth defects specifically on a 129Sv Â BALB/c genetic background, phenotypes which are fully rescued by breeding into a C57BL/6 background (Cobrinik et al., 1996; Lee et al., 1996; LeCouter et al., 1998a, b) . Additionally, loss of E2f3 results in fully penetrant embryonic lethality on a 129Sv genetic background, whereas many E2f3-deficient animals live to adulthood on a 129Sv Â C57BL/6 background (Humbert et al., 2000; Cloud et al., 2002) . The 129Sv modifiers responsible for enhanced ILP tumorigenesis in Rb þ /À animals may also be responsible for some of these strain-specific effects.
Surprisingly, about 20-25% of humans develop pituitary tumors detected by imaging in the clinic or upon autopsy, many of which are associated with clinical symptoms (Asa and Ezzat, 2002). However, human pituitary tumors arise from the ALP, and not from the ILP, which is vestigial in humans. In human pituitary adenomas, loss of heterozygosity at 13q (which includes RB at 13q14) and methylation of CpG islands in the human RB promoter resulting in loss of expression have been reported (Cryns et al., 1993; Simpson et al., 2000) ; however, inactivating mutations specifically in RB have not been found in pituitary adenomas. Prior to this study, it has been generally accepted that the ILP tumorigenesis mediated by the inactivation of Rb in mice is not applicable to the ALP tumorigenesis in humans. The prominent induction of severe ALP tumors that we now report in Rb þ /À mice on the C57BL/6 genetic background (Figure 2 , 65% for the C57BL/6 G5-G8 cohort and Table 2) suggests that there is at least one C57BL/6 genetic modifier responsible for the enhanced ALP tumor penetrance. In fact, aged wild-type C57BL/6 mice are known to develop moderate ALP lesions. ALP tumors occurring at low penetrance (22%) have been reported previously in Rb þ /À mice (Nikitin et al., 1999) ; however, no influence or regulation by the C57BL/6 genetic background had been uncovered. The strong increase in ALP tumors in the Rb þ /À mice on the C57BL/6 background means that we have increased the utility of the Rb þ /À pituitary tumor phenotype, facilitating the study of ALP tumor models in mice. Our observation that more than half of the ALP tumors in the G0 cohort stain positively for a-GSU, the common subunit for TSH, LH and FSH, suggests that Rb þ /À mice on a C57BL/6 background will be very valuable for the study of a variety of tumors arising from the ALP.
Materials and methods

Generation and genotyping of Rb þ /À animals
An Rb þ /À founder E2800 from the G0 cohort (129Sv Â C57BL/6 mixed genetic background) was backcrossed to either the 129S4/SvJae (referred to as 129Sv) or C57BL/6 strain. His Rb þ /À progeny were successively backcrossed 9-10 additional times to generate Rb þ /À animals enriched in the 129Sv or C57BL/6 genetic background. Generations (G) were grouped as follows to establish the 129Sv and C57BL/6 Rb þ /À cohorts: 129Sv G1-G4, 129Sv G5-G8, 129Sv G9-G10 and C57BL/6 G2-G4, C57BL/6 G5-G8. All animals were maintained in a barrier facility maintained with the oversight of an institutional veterinarian and the Columbia University IACUC, which comply with federal guidelines for the use of research animals. We note that the presence of three black-coated animals in the 129Sv G1 generation suggests that interbreeding had occurred although none of our mating records indicate such activity. Rb þ /À genotyping was performed using two sets of primers throughout the course of this study, the first set (X3 and I3 for the wild-type allele, and PGK and X3 for the mutant allele) being that previously described (Jacks et al., 1992) . The second set of primers includes L116 (5 0 GGGATTTGGGACCAATAAT-GAAT 3 0 , a forward primer lying in the intron downstream of exon 3) and I3 to detect the wild-type allele, or L249 (5 0 AGAGCCCTTGGAGCTGGAGTTAG 3 0 , another forward primer lying in the intron downstream from exon 3) and L251 (5 0 GATTCCCACTTTGTGGTTCTAAG 3 0 , a primer lying within the neo R cassette) to detect the mutant Rb allele. Genotyping was performed on tail DNA upon weaning and was confirmed with ear DNA upon killing of the animals.
Histopathological analysis
Animals from the G0 cohort and each successive backcross were allowed to survive until just before their natural endpoint or collected at 3 and 6 months of age at the 129Sv G10 or C57BL/6 G10-G11 generation, then killed by CO 2 asphyxiation. Their tissues were inspected upon gross dissection, then fixed in 10% PBS buffered formalin for further analysis. The pituitary and thyroid glands recovered from each animal were processed routinely in graded ethanol solutions, embedded in paraffin blocks and sectioned (5 mm) serially for histopathological analysis. Sections containing normal and neoplastic regions were stained with hematoxylin and eosin (H&E) and examined histopathologically to assess the penetrance of the ILP, ALP and thyroid tumors. For almost all of the cohorts, confirmation of the tumor type was obtained by staining for different hormones produced by that tumor (see Immunohistochemical analysis). Pituitary tumor size was determined upon gross dissection and sectioning, while thyroid tumor diameter was determined by measuring the tumor section under a dissecting microscope.
Immunohistochemical analysis
Sections were de-waxed and re-hydrated and underwent various treatments for antibody staining. For hormone detection, endogenous peroxidase activity was blocked in 3% H 2 O 2 /methanol for 10 min, and epitope exposure was performed by boiling in 10 mM sodium citrate treatment (pH 6.0). Tissues were blocked with CAS Block (Zymed) for 20 min at room temperature followed by 10 min at 41C, and incubated overnight at 41C with antihormone antibodies (1 : 250 in 3% bovine serum albumin in PBS). The a-MSH, growth hormone and calcitonin antibodies were obtained from Peninsula Laboratories/Bachem, and the a-GSU antibody was obtained from A Parlow, NIKDDPD). Signal was amplified with goat anti-rabbit secondary horseradish peroxidase (10 min at room temperature), followed by chromagen detection using DAB (10 min) and hematoxylin counterstaining. For scoring dopaminergic innervation, epitope exposure was performed by boiling in 10 mM sodium citrate, then the blocking of endogenous peroxidase activity and crossreactivity was performed using the Ultravision Mouse Tissue Detection System, Anti-Mouse, HRP Ready-To-Use Kit (LabVision), as per the protocol provided. Tissues were incubated with antityrosine hydroxylase and anti-glial fibrillary acidic protein antibodies (Vector Laboratories) (1 : 20 in 10% fetal bovine serum in RPMI medium) overnight at 41C. Sections were then incubated with biotinylated goat anti-mouse antibody for 30 min, followed by streptavidin peroxidase (Vectastain ABC Kit, Vector Laboratories) for 10 min, chromagen detection using DAB (10 min) and hematoxylin counterstaining.
Statistical analyses
Differences in the survival of animals were analysed using ANOVA analysis with Bonferroni correction. Differences in tumor penetrance were analysed using the w 2 test. Differences in tumor severity were analysed with a two-sample t-test with unequal variance. Early lesion time point differences were analysed using w 2 tests.
